Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.
Zalcberg J, Millward M, Bishop J, McKeage M, Zimet A, Toner G, Friedlander M, Barter C, Rischin D, Loret C, James R, Bougan N, Berille J.
Zalcberg J, et al. Among authors: rischin d.
J Clin Oncol. 1998 May;16(5):1948-53. doi: 10.1200/JCO.1998.16.5.1948.
J Clin Oncol. 1998.
PMID: 9586914
Clinical Trial.